• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Vaccine could boost survival for node-negative melanoma

Article

Ann Arbor, Mich. - An allogeneic melanoma vaccine - Melacine, made by Corixa Corp. - might provide a survival benefit in node-negative melanoma patients expressing specific HLA class I antigens, according to recent reports.

Related Videos
Related Content
Tracee Blackburn, PA-C: Gut Health for Healthy Skin

Tracee Blackburn, PA-C: Gut Health for Healthy Skin

Article
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Podcast
QUIZ RECAP: Test Your Knowledge of Rosacea Complications and Comorbidities

QUIZ RECAP: Test Your Knowledge of Rosacea Complications and Comorbidities

Article
ReV Up Your Vitiligo Treatment Strategies

ReV Up Your Vitiligo Treatment Strategies

Podcast
Brittany Scurto, PA-C: How to Discuss an Integrative Medicine Approach With Patients

Brittany Scurto, PA-C: How to Discuss an Integrative Medicine Approach With Patients

Article
Introducing Omar Noor, MD, FAAD: Dermatology Times' Newest Editorial Advisory Board Member

Introducing Omar Noor, MD, FAAD: Dermatology Times' Newest Editorial Advisory Board Member

Article
© 2024 MJH Life Sciences

All rights reserved.